0.0500
0.0000
(0.00%)
At close: January 30 at 3:46:44 PM EST
Breakdown
TTM
10/31/2023
10/31/2022
10/31/2021
10/31/2020
Operating Cash Flow
-2,025.0030
-1,757.5120
-2,177.5120
-2,158.2270
-2,112.1040
Investing Cash Flow
--
--
--
--
-46.9700
Financing Cash Flow
1,598.3940
1,749.5260
2,036.6590
1,450.0480
-45.9560
End Cash Position
-117.7620
571.4940
421.5190
778.0060
1,535.8730
Capital Expenditure
--
--
--
--
-46.9700
Repayment of Debt
--
-35.5400
-35.7210
-308.2610
-133.3830
Free Cash Flow
-2,025.0030
-1,757.5120
-2,177.5120
-2,158.2270
-2,159.0740
10/31/2020 - 7/10/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GSD.V Devonian Health Group Inc.
0.1700
0.00%
NGEN.V NervGen Pharma Corp.
2.8900
+1.05%
QPTFF Quest PharmaTech Inc.
0.0133
0.00%
IPHYF Innate Pharma S.A.
2.9000
0.00%
QPT.V Quest PharmaTech Inc.
0.0350
0.00%
ALGEN.PA genOway Société anonyme
3.4600
+1.76%
HBP.TO Helix BioPharma Corp.
0.9200
0.00%
UCBJY UCB SA
97.18
-0.85%
AGN.CN Algernon Pharmaceuticals Inc.
0.0800
0.00%
METX.CN METheraHld
8.00
0.00%